Rosenberg Ellen's Form 4 filing
Amicus Therapeutics, Inc.FOLD · filed Jan 4, 2024
- Accession no.
- 0000950170-24-002111
- Filed
- Jan 4, 2024
- Trade date
- Jan 2-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $426.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenberg EllenCIK 0001666380 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseAcquired | +30,000 | $5.16 | +$154,800 | 372,285 | Direct | |
| Jan 2, 2024 | Common Stock | SSaleDisposed | −30,000 | $14.21F1 | −$426,300 | 342,285 | Direct | |
| Jan 2, 2024 | Common Stock | AGrant or awardAcquired | +63,131 | $0.00 | $0 | 405,416 | Direct | |
| Jan 2, 2024 | Common Stock | FTax withholdingDisposed | −6,985 | $14.24 | −$99,466.4 | 398,431 | Direct | |
| Jan 3, 2024 | Common Stock | FTax withholdingDisposed | −15,397 | $13.53 | −$208,321.41 | 383,034 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 30,000 | Direct | |
| Jan 2, 2024 | Common Stock | AGrant or awardAcquired | +108,980 | $0.00 | $0 | 108,980 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.35 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2023.